Skip to main content
. 2018 Oct 2;2018:7074868. doi: 10.1155/2018/7074868

Figure 2.

Figure 2

Pathogenesis of SGLT-2 inhibitor-associated EDKA. EGP: endogenous glucose production; TGD: tissue glucose disposal.